Bolt Biotherapeutics, Inc. (BOLT)
4.90
-0.19
(-3.73%)
USD |
NASDAQ |
Feb 25, 16:00
4.90
0.00 (0.00%)
After-Hours: 20:00
Bolt Biotherapeutics EPS Diluted (Quarterly) : -3.722 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.144M |
| Revenue (Quarterly) | 2.169M |
| Total Expenses (Quarterly) | 9.313M |
| Enterprise Value | 0.6647M |
| Gross Profit Margin (Quarterly) | 86.63% |
| Profit Margin (Quarterly) | -329.4% |
| Earnings Yield | -342.8% |
| Normalized Earnings Yield | -333.53 |